Insights

345 Park Avenue South

Events

Cure Presents: The X Factor Healthcare Innovation Summit

Magenta

Blue

News & Insights

Your Home in NYC

Cure Founders Pass Membership Benefits 03 Tab Bar Image

Dark Blue

Membership

Accelerating Advances in Health

Green

About

Contact us

## About
Marion E. Glick is a writer, editor and content creator with deep expertise in medical and life science communications. Glick’s passion lies in translating complex topics ranging from basic research to public health to the business of healthcare innovation into clear, compelling and engaging narratives.

## Experience
Glick's career includes senior roles in communications, notably as Senior Vice President at Porter Novelli and Vice President at Noonan/Russo Communications, where her clients included global pharmaceutical, biotech, and diagnostic companies, as well as academic medical centers and government agencies. Additionally, Glick served as Director of Communications at The Rockefeller University, managing landmark announcements in biomedical research, and held pivotal communications roles at the National Institute of Allergy and Infectious Diseases and The Johns Hopkins Medical Institutions. She is a member of the National Association of Science Writers.

## Education
Glick earned her M.A. in journalism/science communication from the University of Maryland, College Park, and holds a B.S. in biology from Muhlenberg College. She also completed credited coursework in science journalism, public relations, and liberal arts at Lehigh University and Albright College.

Contributing Editor and Writer

Equal Research Day highlights the persistent disparity of women in medical research and elevates leaders working to change that. Cure spotlights seven women shaping a more equitable future in healthcare innovation.

7 Women Advocates Who Drive Gender Equity in Health Research image 1

7 Women Advocates Who Drive Gender Equity in Health Research

Wandercraft launches its first U.S. clinic in New York City, offering people with spinal cord injuries, stroke, and other neurological conditions personalized neurorehabilitation using its self-balancing Atalante X exoskeleton.

Wandercraft’s ‘Walk in New York’ Clinic Opens for Hands-Free Exoskeleton Therapy

During the 2025 XSeed Award ceremony, a panel of biotech investors, policy experts, and founders offered hard-earned advice to early-stage entrepreneurs navigating a volatile funding landscape.

Experts Urge Healthcare Startups to Stay Bold, Focused, and Patient-Centered

Two NYC-based startups, GenKardia and Sidereal Therapeutics, have each won a $250,000 XSeed Award to support moving promising preclinical research of novel therapies for kidney and heart disease forward toward commercialization.

$250K XSeed Awards Granted to Minority- and Women-Led Startups Advancing New Drugs 

Healthcare innovators can network and learn at upcoming 2025 conferences that bring together life science, biotech and entrepreneurship thought leaders.

5 Top Conferences for Healthcare Innovators Image

What 2025 Events are Must-Attends for Healthcare Innovators?

The Power of X Summit gathers entrepreneurs, finance, policy and scientific leaders to address investment gaps and accelerate innovation in women’s health.

Power of X Summit Makes Investment Case for Women’s Health

Thought leaders at Cure's event, March 24 -25, 2025, will share insights and resources to help healthcare innovators build investment cases and business strategies to progress solutions for the health of women to market. 

Power of X Summit: Solutions for an Untapped Market, March 24-25, 2025

Power of X Summit to Drive Investing in Health of Women

With over 10,000 known rare diseases to address, Global Genes is expanding its RARE-X program to drive innovation.

Global Genes Expands Rare Disease Research and Advocacy image

Global Genes Expands Rare Disease Research and Advocacy

With compelling narratives and expert insights, Pao’s book "Breakthrough: The Quest for Life-Changing Medicines" offers readers a rare glimpse into the intersection of science, perseverance, and human impact.

New Book Chronicles Journey Behind Life-Saving Medicines

Using machine learning to take on drug overdoses earned Dean Wang a finalist position in the 2024 BioGENEius Challenge.

 2024 BioGENEius Challenge Finalist Dean Wang

Spotlight on 2024 BioGENEius Challenge Finalist: Dean Wang

ARPA-H Director Renee Wegrzyn, PhD, joins Cure CEO Seema Kumar in showcasing Ancilia Biosciences, Aspira Women's Health, Celmatix, Gameto and Glaucus.

arpa-h-celebrates-sprint-for-womens-health 

Cure Event Honors ARPA-H Sprint for Women's Health Awardees

Developing a novel soft-robotics system to take on bed sores earned Porter Mikesell a finalist position in the 2024 BioGENEius Challenge. 

November 11 -13 , 2025